BNP Paribas Financial Markets
VRXAW

BNP Paribas Financial Markets’s Veraxa Biotech AG Warrants VRXAW Stock Holding History

BNP Paribas Financial Markets’s Portfolio VRXAW Stock Details VRXAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.9K Buy
+253,207
New +$44.7K ﹤0.01% 5153

Other funds holding VRXAW

AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.34% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.8% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $489M AUM 9.58% 1-Year Est. Return

BNP Paribas Financial Markets's VRXAW Position: Q2 2026 in Review

BNP Paribas Financial Markets opened a new position in Veraxa Biotech AG Warrants (VRXAW) in Q2 2026: 253,207 shares worth $27.9K. The stake represents ﹤0.01% of the portfolio and ranks #5153 among its holdings.

9 funds tracked by Wall St. Rank hold VRXAW as of Q2 2026.

  • BNP Paribas Financial Markets held 253,207 shares of Veraxa Biotech AG Warrants worth $27.9K as of Q2 2026.
  • Veraxa Biotech AG Warrants was a new BNP Paribas Financial Markets position in Q2 2026.
  • Veraxa Biotech AG Warrants made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5153 holding.
  • 9 funds tracked by Wall St. Rank held Veraxa Biotech AG Warrants as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.